Jump to content Jump to search
Symbolbild Neurone im Raum

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.
Derrick Robertson et al., Front Immunol. 2026

Derrick Robertson, Enrique Alvarez, Lawrence Steinman, Hans-Peter Hartung, Peiqing Qian, Krzysztof Selmaj, Sibyl Wray, Daniel Wynn, Edward J Fox, Koby Mok, Hari P Miskin, Yihuan Xu, Christopher A Garner, Bruce A C Cree.

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.

Front Immunol. 2026 May 29:17:1771848. doi: 10.3389/fimmu.2026.1771848. eCollection 2026. PubMed ID: 42292352

 

Further Information:

DOI: 10.3389/fimmu.2026.1771848

Hans-Peter Hartung

Kategorie/n: NND-Publikationen